# Study of Paliperidone ER in Adolescents and Young Adults With Autism

> **NCT00549562** · PHASE3 · COMPLETED · sponsor: **Indiana University** · enrollment: 25 (actual)

## Conditions studied

- Autism

## Interventions

- **DRUG:** Paliperidone ER

## Key facts

- **NCT ID:** NCT00549562
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2017-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00549562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00549562, "Study of Paliperidone ER in Adolescents and Young Adults With Autism". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00549562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*